is supported as a Canada Research Chair and by CIHR #142773
Depending on the degree of the deficiency, your doctor may recommend that you receive subsequent injections over a few weeks or ongoing, routine appointments
The EMPA-REG and CANVAS trials showed that the SGLT-2i empagliflozin and SGLT-1/2i canagliflozin reduced the risk of MACE in T2D patients with or at high risk of CVD by 14%, while the SGLT-2i dapagliflozin did not significantly reduce the risk of MACE, possibly due to the difference in population (approximately 60% with no established ASCVD) between previous trials and strict exclusion criteria
213,214,215 These genetic variants act as proxies for prolonged urate exposure, assuming they remain unconfounded by other factors
Nocturnal hypoglycaemia is more likely when Ozempic is used alongside insulin or sulphonylureas, and can cause night sweats, nightmares, or early morning awakenings
Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications
